Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Baba Inusa

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
Pediatric Blood & Cancer|March 27, 2015
13-valent pneumococcal conjugate vaccine (PCV13) is immunogenic and safe in children 6-17 years of age with sickle cell disease previously vaccinated with 23-valent pneumococcal polysaccharide vaccine (PPSV23): Results of a phase 3 studyMariane De Montalembert, Miguel R Abboud, Anne Fiquet, et al.
Trials|October 11, 2021
Study of montelukast in children with sickle cell disease (SMILES): a study protocol for a randomised controlled trialAnna M Hood, Hanne Stotesbury, Melanie Kölbel, et al.
Hemasphere|December 10, 2025
HELIOS Action: Advancing research, education, and equity in hemoglobinopathies across Europe and beyondSotiroula Chatzimatthaiou, Fedele Bonifazi, Anna C Gimbert, et al.
Journal of Women'S Health (2002)|November 27, 2023
Pain Frequency and Health Care Utilization Patterns in Women with Sickle Cell Disease Experiencing Menstruation-Associated Pain CrisesCatherine Segbefia, Jillian Campbell, Immacolata Tartaglione, et al.
Journal of Sickle Cell Disease|December 15, 2025
International variations in body mass index within the CASiRe global cohort of sickle cell disease patientsCrawford Strunk, Angela Rivers, Catherine Segbefia, et al.
Blood Cells, Molecules & Diseases|September 26, 2021
Global geographic differences in healthcare utilization for sickle cell disease pain crises in the CASiRe cohortCrawford Strunk, Immacolata Tartaglione, Connie M Piccone, et al.
Pain Medicine (Malden, Mass.)|February 15, 2022
Pain Burden in the CASiRe International Cohort of Sickle Cell Patients: United States and GhanaWilliam T Zempsky, Mary Yanaros, Mohammed Sayeem, et al.
Trials|January 24, 2018
Overnight auto-adjusting continuous airway pressure + standard care compared with standard care alone in the prevention of morbidity in sickle cell disease phase II (POMS2b): study protocol for a randomised controlled trialJo Howard, April E Slee, Simon Skene, et al.
Haematologica|October 15, 2020
Real-time national survey of COVID-19 in hemoglobinopathy and rare inherited anemia patientsPaul Telfer, Josu De la Fuente, Mamta Sohal, et al.
American Journal of Hematology|July 22, 2014
Silent cerebral infarction, income, and grade retention among students with sickle cell anemiaAllison A King, Mark J Rodeghier, Julie Ann Panepinto, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Pediatric Blood & Cancer|March 27, 2015
13-valent pneumococcal conjugate vaccine (PCV13) is immunogenic and safe in children 6-17 years of age with sickle cell disease previously vaccinated with 23-valent pneumococcal polysaccharide vaccine (PPSV23): Results of a phase 3 studyMariane De Montalembert, Miguel R Abboud, Anne Fiquet, et al.
Trials|October 11, 2021
Study of montelukast in children with sickle cell disease (SMILES): a study protocol for a randomised controlled trialAnna M Hood, Hanne Stotesbury, Melanie Kölbel, et al.
Hemasphere|December 10, 2025
HELIOS Action: Advancing research, education, and equity in hemoglobinopathies across Europe and beyondSotiroula Chatzimatthaiou, Fedele Bonifazi, Anna C Gimbert, et al.
Journal of Women'S Health (2002)|November 27, 2023
Pain Frequency and Health Care Utilization Patterns in Women with Sickle Cell Disease Experiencing Menstruation-Associated Pain CrisesCatherine Segbefia, Jillian Campbell, Immacolata Tartaglione, et al.
Journal of Sickle Cell Disease|December 15, 2025
International variations in body mass index within the CASiRe global cohort of sickle cell disease patientsCrawford Strunk, Angela Rivers, Catherine Segbefia, et al.
Blood Cells, Molecules & Diseases|September 26, 2021
Global geographic differences in healthcare utilization for sickle cell disease pain crises in the CASiRe cohortCrawford Strunk, Immacolata Tartaglione, Connie M Piccone, et al.
Pain Medicine (Malden, Mass.)|February 15, 2022
Pain Burden in the CASiRe International Cohort of Sickle Cell Patients: United States and GhanaWilliam T Zempsky, Mary Yanaros, Mohammed Sayeem, et al.
Trials|January 24, 2018
Overnight auto-adjusting continuous airway pressure + standard care compared with standard care alone in the prevention of morbidity in sickle cell disease phase II (POMS2b): study protocol for a randomised controlled trialJo Howard, April E Slee, Simon Skene, et al.
Haematologica|October 15, 2020
Real-time national survey of COVID-19 in hemoglobinopathy and rare inherited anemia patientsPaul Telfer, Josu De la Fuente, Mamta Sohal, et al.
American Journal of Hematology|July 22, 2014
Silent cerebral infarction, income, and grade retention among students with sickle cell anemiaAllison A King, Mark J Rodeghier, Julie Ann Panepinto, et al.
Pageof 8